
New study demonstrates SARS-CoV-2 Omicron antibody escape
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China in December 2019, leading to a worldwide outbreak of coronavirus disease...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in Wuhan, China in December 2019, leading to a worldwide outbreak of coronavirus disease...
Acute lymphoblastic leukemia (ALL) cells from patients whose cancers did not respond to CD19-targeted CAR T therapy had gene regulation signatures that could potentially facilitate...
Mount Sinai scientists have become the first to report a potentially serious side effect related to a new form of immunotherapy known as CAR-T cell...
In a study posted to the bioRxiv* preprint server, a team of researchers from Germany studied the expression data of severe acute respiratory syndrome coronavirus...
Physicians prescribed significantly more guideline-directed medications for heart failure if they received a customized digital alert via an electronic health record (EHR) system when inputting...
When something disrupts hormone binding to the receptor, such as environmental compounds or pollutants, called endocrine disrupting chemicals (EDCs), the results can be harmful and,...
Since its discovery in December 2019, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has spread swiftly and resulted...
The coronavirus disease 2019 (COVID-19) pandemic has caused several waves of infections in many world regions, so strong as to overwhelm local healthcare services. In...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) consists of four major structural proteins, of which include the spike (S), membrane (M), envelope (E), and...
In a recent study, researchers used computational structural biology methods to analyze the role of mutations in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
An international research team co-led by scientists at Roswell Park Comprehensive Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James...
Numerous vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed, including two novel mRNA vaccines, Moderna mRNA-1273 and Pfizer/BioNTech BNT162b2. Coronavirus disease...